These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Characteristics and use of blood transfusion and blood components in the treatment of patients with hemostasis disorders: II. Levels of coagulation factors]. Grgicević D; Pistotnik M Lijec Vjesn; 1986 Jun; 108(6):274-7. PubMed ID: 3724356 [No Abstract] [Full Text] [Related]
4. [CLINICAL ASPECTS AND TREATMENT OF HEMOPHILIA IN CHILDREN]. STEPANOVA MN; DUBROV EIa Sov Med; 1964 Mar; 27():104-9. PubMed ID: 14177334 [No Abstract] [Full Text] [Related]
13. [Blood coagulation and its disorders in portal hypertension]. Lasch HG Verh Dtsch Ges Inn Med; 1976; 82 Pt 1():190-8. PubMed ID: 1029181 [No Abstract] [Full Text] [Related]
14. STUDIES ON CLOT PROMOTING SERUM FACTOR (S) (CPSF) IN VITRO EXPERIMENTS. YOSHIDA Y Tohoku J Exp Med; 1964 Apr; 82():276-91. PubMed ID: 14166838 [No Abstract] [Full Text] [Related]
15. [Basic principles of hemotherapy]. Dobrý E Cesk Pediatr; 1969 Feb; 24(2):153-8. PubMed ID: 5783487 [No Abstract] [Full Text] [Related]
16. Deficiency of fibrin-stabilizing factor. Br Med J; 1965 Oct; 2(5469):1013-4. PubMed ID: 5826288 [No Abstract] [Full Text] [Related]
17. [Directed hemotherapy of hemorrhage in internal medicine]. Glassner K; Schneider W; Fröhlich C Med Welt; 1972 Sep; 23(40):1393. PubMed ID: 4655582 [No Abstract] [Full Text] [Related]
18. Factor XIII deficiency. Treatment with monthly plasma infusions. Greenberg LH; Schiffman S; Wong YS JAMA; 1969 Jul; 209(2):264-5. PubMed ID: 5819238 [No Abstract] [Full Text] [Related]
19. [Possibilities and limits of modern hemotherapy]. István L Orv Hetil; 1978 Dec; 119(50):3043-54. PubMed ID: 733225 [No Abstract] [Full Text] [Related]